{
    "Symbol": "ILMN",
    "AssetType": "Common Stock",
    "Name": "Illumina Inc",
    "Description": "Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.",
    "CIK": "1110803",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "LABORATORY ANALYTICAL INSTRUMENTS",
    "Address": "5200 ILLUMINA WAY, SAN DIEGO, CA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "18749610000",
    "EBITDA": "345000000",
    "PERatio": "None",
    "PEGRatio": "0.579",
    "BookValue": "36.06",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-8.15",
    "RevenuePerShareTTM": "28.39",
    "ProfitMargin": "-0.287",
    "OperatingMarginTTM": "-0.0548",
    "ReturnOnAssetsTTM": "-0.005",
    "ReturnOnEquityTTM": "-0.208",
    "RevenueTTM": "4493000000",
    "GrossProfitTTM": "3145000000",
    "DilutedEPSTTM": "-8.15",
    "QuarterlyEarningsGrowthYOY": "-0.965",
    "QuarterlyRevenueGrowthYOY": "-0.01",
    "AnalystTargetPrice": "142.29",
    "AnalystRatingStrongBuy": "5",
    "AnalystRatingBuy": "4",
    "AnalystRatingHold": "14",
    "AnalystRatingSell": "2",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "40.82",
    "PriceToSalesRatioTTM": "4.173",
    "PriceToBookRatio": "3.27",
    "EVToRevenue": "4.433",
    "EVToEBITDA": "51.88",
    "Beta": "1.15",
    "52WeekHigh": "190.13",
    "52WeekLow": "86.49",
    "50DayMovingAverage": "109.74",
    "200DayMovingAverage": "119.21",
    "SharesOutstanding": "159300000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}